A detailed history of Voya Investment Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 17,527 shares of MDGL stock, worth $4.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,527
Previous 13,003 34.79%
Holding current value
$4.91 Million
Previous $3.01 Million 55.59%
% of portfolio
0.01%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$171.37 - $283.23 $775,277 - $1.28 Million
4,524 Added 34.79%
17,527 $4.68 Million
Q4 2023

Feb 14, 2024

BUY
$120.4 - $237.13 $342,778 - $675,109
2,847 Added 28.03%
13,003 $3.01 Million
Q3 2023

Nov 14, 2023

SELL
$146.04 - $225.78 $2.22 Million - $3.43 Million
-15,189 Reduced 59.93%
10,156 $1.48 Million
Q2 2023

Aug 14, 2023

BUY
$203.88 - $312.0 $3.64 Million - $5.57 Million
17,843 Added 237.84%
25,345 $5.85 Million
Q1 2023

May 15, 2023

SELL
$231.06 - $307.08 $1.19 Million - $1.59 Million
-5,168 Reduced 40.79%
7,502 $1.82 Million
Q4 2022

Feb 14, 2023

BUY
$58.39 - $296.54 $165,535 - $840,690
2,835 Added 28.83%
12,670 $3.68 Million
Q3 2022

Mar 03, 2023

SELL
$60.57 - $79.51 $171,715 - $225,410
-2,835 Reduced 22.38%
9,835 $639,000
Q3 2022

Nov 14, 2022

BUY
$60.57 - $79.51 $306,544 - $402,400
5,061 Added 106.01%
9,835 $639,000
Q2 2022

Aug 15, 2022

BUY
$58.04 - $100.2 $7,487 - $12,925
129 Added 2.78%
4,774 $342,000
Q1 2022

May 16, 2022

BUY
$55.89 - $101.89 $10,619 - $19,359
190 Added 4.26%
4,645 $456,000
Q4 2021

Feb 14, 2022

BUY
$72.34 - $95.09 $7,595 - $9,984
105 Added 2.41%
4,455 $378,000
Q2 2021

Aug 16, 2021

BUY
$97.2 - $137.59 $39,366 - $55,723
405 Added 10.27%
4,350 $424,000
Q1 2021

May 17, 2021

BUY
$108.54 - $125.2 $21,925 - $25,290
202 Added 5.4%
3,945 $461,000
Q4 2020

Feb 16, 2021

BUY
$110.06 - $133.7 $71,428 - $86,771
649 Added 20.98%
3,743 $416,000
Q2 2020

Aug 14, 2020

SELL
$60.13 - $125.71 $63,797 - $133,378
-1,061 Reduced 25.54%
3,094 $350,000
Q1 2020

May 15, 2020

BUY
$66.76 - $93.49 $24,500 - $34,310
367 Added 9.69%
4,155 $277,000
Q4 2019

Feb 14, 2020

BUY
$84.28 - $118.5 $70,373 - $98,947
835 Added 28.28%
3,788 $345,000
Q2 2019

Aug 14, 2019

BUY
$91.13 - $142.5 $8,110 - $12,682
89 Added 3.11%
2,953 $310,000
Q4 2018

Feb 14, 2019

BUY
$94.77 - $215.54 $20,375 - $46,341
215 Added 8.12%
2,864 $323,000
Q3 2018

Nov 14, 2018

BUY
$207.3 - $300.31 $73,591 - $106,610
355 Added 15.48%
2,649 $567,000
Q2 2018

Aug 14, 2018

BUY
$101.55 - $313.9 $37,979 - $117,398
374 Added 19.48%
2,294 $642,000
Q1 2018

May 15, 2018

BUY
$93.35 - $149.04 $179,232 - $286,156
1,920 New
1,920 $224,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $4.79B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.